As of June 19, 2025, Laboratory Corporation of America Holdings (LH) reports a Net Margin of 5.73%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of Laboratory Corporation of America Holdings's Net Margin
Over recent years, Laboratory Corporation of America Holdings's Net Margin has shown significant volatility. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2024-12-31 | 5.73% |
| 2023-12-31 | 3.44% |
| 2022-12-31 | 10.78% |
| 2021-12-31 | 18.10% |
| 2020-12-31 | 11.13% |
This slight upward trend highlights how Laboratory Corporation of America Holdings manages its overall profitability and cost control over time.
Comparing Laboratory Corporation of America Holdings's Net Margin to Peers
To better understand Laboratory Corporation of America Holdings's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| Laboratory Corporation of America Holdings (LH) | 5.73% |
| Chemed Corp (CHE) | 12.42% |
| Heartbeam Inc (BEAT) | 10.72% |
| CorVel Corp (CRVL) | 10.63% |
| Quest Diagnostics Inc (DGX) | 8.82% |
| DaVita Inc (DVA) | 7.31% |
Compared to its competitors, Laboratory Corporation of America Holdings's Net Margin is about average compared to peers, reflecting typical industry profitability.